Nightfood Holdings Appoints Proven Operators to Accelerate Public Company Growth and Hospitality Innovation
TARRYTOWN, N.Y., May 01, 2025 (GLOBE NEWSWIRE) -- via IBN – Nightfood Holdings, Inc. (OTCQB: NGTF), an emerging leader in AI-driven hospitality automation and real estate-backed hotel operations, today announced the appointment of Jimmy Chan as Chief Executive Officer and Ried Floco as President and Director.
These leadership transitions mark a pivotal moment in Nightfood's evolution, aligning the company with two seasoned executives whose combined experience in scaling businesses, leveraging automation, and operating in public market environments will drive long-term shareholder value and disciplined growth.
Jimmy Chan brings more than 20 years of entrepreneurial and capital markets expertise across industries including real estate, international trade, healthcare, and hospitality supply. As the founder of CarryOutSupplies.com, he scaled one of the largest custom-printed foodservice packaging providers in North America, serving thousands of hotels and restaurants. Mr. Chan is a recognized leader in operational optimization, vertical integration, and supply chain innovation. His experience in taking companies public, executing M&A transactions, and restructuring businesses for long-term value creation will support Nightfood's corporate development, capital markets strategy, and execution as a high-growth public enterprise.
Ried Floco, with over three decades of executive leadership across the hospitality sector, has overseen the performance of more than 200 hotel properties and $3 billion in asset valuations. He has led operations across top-tier brands such as Marriott, Hilton, Intercontinental, and Starwood Hotels. Mr. Floco will drive Nightfood's Robotics-as-a-Service (RaaS) platform deployment across hospitality verticals while simultaneously leading the company's hotel asset acquisition strategy. His deep operational insight will ensure that the integration of AI-powered automation with real estate ownership delivers scalable and efficient performance in Nightfood's expanding portfolio.
Sonny Wang, who previously served as CEO, has transitioned to the role of Chief Revenue Officer, where he will focus on revenue maximization across the Company's core verticals—AI robotics, hotel operations, and hospitality supply chain.
'Jimmy and Ried are exactly the kind of leaders we need to build a robust, high-performing public company,' said Jamie Steigerwald, Chairman of Nightfood Holdings. 'Jimmy brings unmatched supply chain expertise and a strategic capital markets perspective, while Ried adds decades of real estate and hotel performance management combined with cutting-edge robotics implementation. Together, they're positioning Nightfood to become a market leader in technology-enabled hospitality.'
These appointments come on the heels of Nightfood's acquisitions of Skytech Automated Solutions and CarryOutSupplies.com, forming a vertically integrated foundation to deliver next-generation service solutions across hotels and foodservice industries.
About Nightfood Holdings, Inc. (OTCQB: NGTF)
Nightfood Holdings, Inc. is transforming the hospitality industry by combining AI-powered service robotics with a strategic real estate-focused hotel acquisition model. Through its dual focus on Robotics-as-a-Service (RaaS) and hotel ownership, Nightfood leverages automation to reduce labor costs, improve guest experiences, and drive operational efficiency. Positioned to lead the growing $170+ billion global service robotics market, Nightfood's integrated strategy offers scalable revenue and high-margin performance.
Forward-Looking Statements
This press release contains forward-looking statements regarding future events and Nightfood Holdings' expected performance. These statements are subject to risks and uncertainties. Actual results may differ materially. Investors are encouraged to review the Company's SEC filings for additional information.
Contacts
Investor RelationsEmail: ir@nightfoodholdings.com
Media RelationsEmail: media@nightfoodholdings.comPhone: (866) 261-7778
Wire Service Contact:IBN – InvestorBrandNetworkAustin, Texaswww.InvestorBrandNetwork.comEditor@InvestorBrandNetwork.comSign in to access your portfolio
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hamilton Spectator
an hour ago
- Hamilton Spectator
Cologix Closes $525 Million USD Asset-Backed Securitization to Support AI Infrastructure, Interconnection and Growth
DENVER, July 21, 2025 (GLOBE NEWSWIRE) — Cologix , a leading network-neutral interconnection and hyperscale edge data center company in North America, today announced that it has closed a $525 million USD asset-backed securitization (ABS) to support the company's continued growth in digital infrastructure. The secured notes are backed by Cologix's COL4 data center in Columbus, Ohio, and structured with a five-year fixed term. This transaction marks Cologix's fourth ABS issuance since 2021 and reflects the company's continued use of the asset-backed securities market to fund growth. Proceeds will support strategic investments across Cologix's Scalelogix℠ and Digital Edge portfolio, enabling the company to address increasing demand for inference AI and cloud workloads. 'This transaction demonstrates the strength of our balance sheet, the continued support of our investor base and the market's confidence in our long-term strategy,' said Scott Schneider, Chief Financial Officer of Cologix. 'As we kick off our next wave of growth, this financing will help us scale critical infrastructure to meet the increasing demands of hyperscale and inference AI applications.' Cologix continues to expand its hyperscale edge footprint across North America, helping customers deploy cloud and AI-ready digital infrastructure at the network edge. This latest ABS financing follows three prior transactions in 2021, 2022 and 2023, further supporting the company's ability to scale critical infrastructure with speed and confidence. 'Our ability to deliver scalable, sustainable and deeply connected data center solutions is a key driver of customer success,' said Laura Ortman, Chief Executive Officer of Cologix. 'This financing ensures we're well-positioned to meet the needs of cloud providers, enterprise and AI customers seeking reliable, high-density interconnection at the edge.' Cologix continues to prioritize operational sustainability in its growth strategy, maintaining average Power Usage Effectiveness (PUE) and Water Usage Effectiveness (WUE) rates that significantly outperform industry benchmarks. These efficiency measures reflect the company's commitment to responsible digital infrastructure development while scaling to meet future needs. Deutsche Bank Securities Inc. served as the lead bank on the transaction and legal counsel was provided by King & Spalding. About Cologix Cologix powers digital infrastructure with 45+ hyperscale edge data centers and interconnection hubs across 12 North American markets, providing high-density, ultra-low latency solutions for cloud providers, carriers and enterprises. With AI-ready, industry-leading facilities, Cologix offers scalable, flexible and sustainable data center options to help its customers accelerate their business at the digital edge. Cologix provides extensive physical and virtual connections, including Access Marketplace, where customers gain fast, reliable and self-service provisioning for on-demand connectivity. For more information, visit Cologix or follow us on LinkedIn and X . Media Contact for Cologix: Shifali Erasmus, Crackle PR cologix@ A photo accompanying this announcement is available at
Hamilton Spectator
an hour ago
- Hamilton Spectator
VNBTC Gains UK FCA Certification, Enhancing Trust in Its Cloud Mining Platform for Simple and Secure Bitcoin Earnings
LONDON, July 21, 2025 (GLOBE NEWSWIRE) — Institutional investment and global interest have driven the Bitcoin price past $120,000. Simultaneously, cloud mining is evolving into a powerful, accessible way to earn cryptocurrency. VNBTC , a cloud mining platform headquartered in the UK, is proud to announce that it has officially received regulatory certification from the UK's Financial Conduct Authority (FCA). This significant milestone marks VNBTC as one of the few legally recognized cloud mining platforms in the global crypto space — reinforcing its commitment to compliance, investor protection, and long-term sustainability. With its new FCA status, VNBTC now offers crypto investors worldwide a higher level of trust and transparency. The certification enables VNBTC to operate under strict regulatory guidelines, adding a legal layer of security to its AI-optimized cloud mining services. Users can now confidently access Bitcoin, Dogecoin, and Litecoin mining contracts knowing they are engaging with a fully licensed and regulated service provider. In 2025, VNBTC has emerged as a standout platform, offering tiered cloud-mining contracts that deliver impressive earning potential, even for beginners. The platform's signature feature? Clearly defined daily ROI and transparent contract mechanics, making it easy to estimate your returns before you invest. Due to these plan structures, the highest-paying Bitcoin contract offers $17,500 ROI. VNBTC credits earnings automatically every 24 hours to your dashboard, so users see their profits grow in real time and can withdraw or reinvest at any time. With millions of investors already using the platform's AI-optimized contracts, many are seeing daily income ranging from modest starter-plan payouts to five-figure profit cycles. VNBTC is making cryptocurrency mining easier, offering multiple ways to earn passively without needing to afford expensive mining rigs. With added benefits like the affiliate program offering 3% and 1.8% referral commission. Now might be the best time to join the future of mining that is globally trusted by millions. Media Contact: James Carter Marketing Specialist A photo accompanying this announcement is available at
Yahoo
an hour ago
- Yahoo
Pharmaceutical Temperature Controlled Packaging Solutions Market Size to Lead USD 11,600 Mn by 2034 Amid Biologics Booms
The global pharmaceutical temperature controlled packaging solutions market size will soar from USD 6,360 million in 2025 and is estimated to hit around USD 11,600 million by 2034, growing at a CAGR of 6.9% from 2025 to 2034. A study published by Statifacts a sister firm of Precedence Research. Ottawa, July 21, 2025 (GLOBE NEWSWIRE) -- According to Statifacts, the global pharmaceutical temperature controlled packaging solutions market size surpassed USD 5,950 million in 2024 and projected to be worth around USD 9,490 million by 2031, accelerating a CAGR of 6.9% during the forecast period 2025 to 2034. Rising demand for biopharmaceuticals, an increase in cold chain logistics, pharmaceutical safety and quality concerns, and the fast growth of the e-commerce sector are driving the growth of the market. This Report is Readily Available for Immediate Delivery, Visit Here to Explore the Report Sample and In-depth Databook Now@ Pharmaceutical Temperature Controlled Packaging Solutions Market Highlights North America held a dominant 32.02% market share in 2024, driven by robust pharmaceutical and biotech infrastructure. Asia Pacific is anticipated to grow at the fastest growth rate in the market during the forecast period due to the growing pharmaceutical manufacturing base. By product, the reusable solutions accounted for 65.34% of market share in 2024, while single-use solutions are projected to grow fastest from 2025 to 2034 due to cost efficiency in small-volume shipments. By product, the single use solutions segment is expected to grow at the fastest rate in the market during the forecast period of 2025 to 2034 due to the increased cost-effectiveness for small volume shipments. By application, the temperature sensitive pharmaceuticals represented 60.09% of the market share in 2024, with vaccines anticipated to experience the highest growth rate during the forecast period. By application, the vaccines segment is projected to experience the highest growth rate in the market between 2025 and 2034 due to growing awareness of vaccine usage and the benefits of herd immunity. Pharmaceutical Temperature Controlled Packaging Solutions Market Size by Product, 2024 to 2034 (USD Million) Segments 2024 2025 2026 2034 Reusable Solutions 3,875.4 4,147.4 4,434.8 7,363.8 Single Use Solutions 2,055.5 2,212.5 2,379.4 4,133.6 Pharmaceutical Temperature Controlled Packaging Solutions Market Size by Application, 2024 to 2034 (USD Million) Segments 2024 2025 2026 2034 Temperature-Sensitive Pharmaceutical 3,563.9 3,810.2 4,070.2 6,704.4 Vaccines 1,646.3 1,783.0 1,929.5 3,525.3 Others 720.7 766.7 814.6 1,267.8 You can place an order or ask any questions, please feel free to contact us at sales@ Pharmaceutical Temperature Controlled Packaging Solutions Market Overview The pharmaceutical temperature controlled packaging solutions market refers to the production, distribution, and application of pharmaceutical controlled packaging, which is a specialized packaging solution designed to maintain a consistent temperature for sensitive products during transportation and storage. This packaging type is important for goods that are temperature sensitive, like biologics, vaccines, pharmaceuticals, perishable food, and chemicals. Temperature controlled packaging includes refrigerated units, containers, and advanced materials like vacuum insulated panels (VIPs) and phase change materials (PCMs) that ensure temperature stability over changing environmental conditions and durations. Rising demand for tamper-evident and child-resistant characters in packaging, rising use of advanced drug delivery systems, rising prevalence of chronic diseases, increasing demand for biopharmaceuticals, and increasing advancements in new drug packaging systems are driving the growth of the pharmaceutical temperature controlled packaging solutions Controlled Pharmaceutical Packaging Solutions Market Size 2025 to 2034 A related Statifacts report on the temperature controlled pharmaceutical packaging solutions market highlights that the market surpassed USD 4,950 million in 2024 and is expected to reach around USD 6,920 million by 2031, also growing at a CAGR of 4.9% from 2025 to 2034. Both markets are propelled by the expanding biopharmaceutical sector, heightened cold chain logistics demand, and stringent safety standards. Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making. Try Before You Buy – Get the Sample Report@ Major Trends in the Pharmaceutical Temperature Controlled Packaging Solutions Market What Principal Factors Shape the Pharmaceutical Temperature Controlled Packaging Solutions Industry? The principal factors that shape the pharmaceutical temperature controlled packaging solutions industry include the rising use of innovative drug delivery systems and increasing demand for biopharmaceuticals. Rising use of innovative drug delivery systems: Innovative drug delivery systems are designed to deliver medications accurately to the target site, reducing side effects and enhancing patient compliance. The benefit of these advancements lies in their ability to provide more effective treatments for many medical conditions. As compared to traditional formulations, the new drug delivery systems (DDSs) have benefits like reducing the toxic and side effects of the drug, reducing drug degradation, improving drug stability, improving drug bioavailability, and maintaining an effective and stable drug concentration. Increasing demand for biopharmaceuticals: Biopharmaceuticals may demonstrate higher efficiency compared to traditional drugs. Their targeted approach allows them to modulate disease pathways more efficiently, resulting in enhanced therapeutic outcomes. Patients experience better disease management and improved symptom relief, which leads to an enhanced quality of life. Biopharmaceuticals are produced by using biological techniques, making them more environmentally friendly and biodegradable. According to a report, India has emerged as a main player in the biopharmaceutical market, with a rapidly growing number of exporters and suppliers. Source: Pyxus Pharmaceuticals Growth Factors in the Pharmaceutical Temperature Controlled Packaging Solutions Market Advancement in new drug packaging systems: Advancement in new drug packaging includes automated packaging, which is multifaceted, ranging from safeguarding regulatory compliance to improving product quality, minimizing human error, and improving efficiency. This can help with error detection and correction. Pharmaceutical packaging is important due to it protects the drugs from contamination, damage, and degradation, and helps to maintain their safety, efficacy, and quality. It also provides important information about the drug, like storage conditions, dosage instructions, and expiry date. Use of advanced drug delivery systems: Recent drug delivery systems are formulated with enhanced properties like sustained delivery, toxicity, stability, specific site targeting, efficacy, increased solubility, increased permeability, and smaller particle size. Advanced drug delivery systems set a promise to resolve the occurrence of major side effects and enhance therapeutic outcomes by increasing the drug concentration at the affected body site. Targeted drug delivery systems can result in enhanced pharmacokinetics, like increased absorption, distribution, metabolism, and excretion (ADME). This may lead to more predictable drug levels and reduced variability in response to treatment. Ready to Dive Deeper? Visit Here to Buy Databook & In-depth Report Now@ Role of Artificial Intelligence (AI) in the Pharmaceutical Temperature Controlled Packaging Solutions Market The use of artificial intelligence (AI) for pharmaceutical labeling compliance allows improved accuracy of regulatory adherence, which stops expired and mislabeled medications from getting to consumers. The benefits of automated packaging are multifaceted, including enhancing product quality, improving efficiency, minimizing human error, and safeguarding regulatory compliance. AI-based cooling systems include sensor systems and advanced analytics that allow real-time cooling optimization. This approach allows accurate temperature control and preventive maintenance. AI can play an important role in packaging manufacturing quality control. It may scan packaging products at many stages of the manufacturing process and detect defects at a micro-level that may be invisible to the human eye. AI-based packaging systems aim to enhance products and provide convenience to consumers. They function by tracing, recording, sensing, detecting, and communicating information. They also include benefits like increased accuracy in deliveries, improved supply chain visibility, reduced costs, and improved efficiency. What Are the Significant Achievements of the Leading Pharmaceutical Temperature Controlled Packaging Solutions Industry? In July 2025, the launch of Nordic Express Pack, the first cold chain packaging solution specifically designed and tested for shipping GLP-1 medications, was announced by Nordic Cold Chain Solutions, a leading provider of temperature-controlled packaging and cold chain solutions. The Nordic Express Pack was purpose-built for this category, delivering a reliable and easy-to-pack solution that helps specialty pharmacies and healthcare distributors keep pace with rising demand and high daily order volumes. Source: Businesswire In January 2025, TailorTemp, a temperature-controlled packaging solution for the pharmaceutical industry, was launched by an international fibre-based packaging solutions company, DS Smith. The product was launched at the Pharmapack Europe 2025 exhibition held in Paris, France. Source: Packaging Gateway How Does IoT Act as an Opportunity for the Pharmaceutical Temperature Controlled Packaging Solutions Market? The Internet of Things (IoT) is a key technology that allows the connectivity of devices and equipment throughout the manufacturing process. In pharmaceutical manufacturing, IoT devices may be used to monitor critical parameters like temperature and humidity, to ensure product quality and safety. The main aim of the IoT is to create an ecosystem that connects everything. Integrating IoT in packaging offers many benefits, including sustainability and waste reduction, consumer engagement and experience, improved product safety and quality control, enhanced supply chain efficiency, and enhanced traceability and transparency. IoT benefits to improve cold chain logistics like predictive maintenance and monitoring of health equipment, cloud data storage and automated reporting, consumer satisfaction, GPS and RFID tracking of shipments, and monitoring of temperature. Sensors may be used in a variety of transportation modes, like air cargo, trucks, or rail freight, to continuously track the temperature of food items, critical pharmaceuticals, and other items that need cold chain logistics. This may be done by attaching an IoT temperature monitor to the outer layer of the package. Pharmaceutical Temperature Controlled Packaging Solutions Market Challenges and Limitations: What Are the Potential Concerns Related to the Pharmaceutical Temperature Controlled Packaging Solutions Market? Limited access to quality medical care and counterfeit drugs, and fake packaging are the potential concerns related to the pharmaceutical temperature controlled packaging solutions market. Limited access to quality medical care: This lack of access to quality medical care results in high rates of malnutrition, maternal mortality, and maternal mortality and also low vaccination rates and low life expectancy. This poor access to healthcare leads to a strong economic burden on the rural poor, and public spending insurance companies have done little to mitigate it. Lack of access to healthcare may be affected due to people with lower incomes being uninsured, and minority groups account for over half of the uninsured population. Medical care disadvantages also include premiums increasing with age, pre-existing exclusion, waiting period for co-payment, and existing health problems. Counterfeit drugs and fake packaging: Counterfeit drugs may be harmful to our health due to being passed off as authentic, may contain no active ingredients, wrong ingredients, contain too much, or too little ingredient at all, or contain other harmful ingredients. Drug counterfeits are caused due to low standards of management, from poor ethical practices in medical institutions and healthcare facilities to corruption in public and private sectors. Fake packaging can lead to economic and social impacts. Brands may suffer significant financial losses and reputational damage. How Did North America Dominate the Pharmaceutical Temperature Controlled Packaging Solutions Market? North America dominated the global pharmaceutical temperature controlled packaging solutions market in 2024. Increasing demand for tamper-evident and child-resistant features in packaging, rising use of innovative drug delivery systems, rising prevalence of chronic diseases, rising demand for biopharmaceuticals, and increasing innovations in new drug packaging systems are driving the growth of the market in the North American region. How Do Temperature Controlled Packaging Solutions Act as a Key to the Pharmaceutical Industry in the United States? In December 2024, the acquisition of a majority stake in Eutecma, a German-based developer of sustainable, modular, and reusable temperature controlled packaging solutions for pharmaceutical cold chain shipments, was announced by a Greenwich-based private investment firm focused exclusively on the healthcare industry, Great Point Partners. Source: Citybiz What to Expect from Asia Pacific's Pharmaceutical Temperature Controlled Packaging Solutions Market? Asia Pacific is anticipated to grow at the fastest rate in the market during the forecast period. Integration of advanced technologies, increasing demand across diverse industries, evolving regulatory environments, and increased demand for sustainable solutions contribute to the growth of the pharmaceutical temperature controlled packaging solutions market. How Do Temperature Controlled Packaging Solutions Act as a Key to the Pharmaceutical Industry in India? In September 2023, the launch of two new temperature-controlled packaging solutions for the pharmaceutical industry, Celsure® XL Pallet Shipper series and Celsure® VIP Multi-Use Parcel Shipper series, was announced by the phase-change material (PCM) technology company Pluss Advanced Technologies (PLUSS). Source: Indian Transport and logistics News Pharmaceutical Temperature Controlled Packaging Solutions Market Scope Report Attribute Key Statistics Market Size in 2024 USD 5,950 Million Market Size in 2025 USD 6,360 Million Market Size in 2030 USD 8,880 Million Market Size in 2032 USD 10,150 Million Market Size by 2034 USD 11,600 Million CAGR 2025-2034 6.9% Leading Region in 2024 North America Fastest Growing Region Asia-Pacific Base Year 2024 Forecast Period 2025 to 2034 Segments Covered By Product, By Application, and By Region Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa Leading Players Pelican Biothermal, Cryopak, Sonoco Products Company, Envirotainer, DS Smith Pharma, Cold Chain Technologies, World Courier, Intelsius, CSafe, Softbox Systems, Skycell, Va-Q-tec AG, Sofrigam, and Others. Pharmaceutical Temperature Controlled Packaging Solutions Market Segmentation Product Insights The reusable segment held a dominant presence in the pharmaceutical temperature controlled packaging solutions market in 2024. Reusable pharmaceutical temperature controlled packaging solutions are cost-efficient and environment-friendly. By reducing the repeated need to manufacture single-use packaging, companies can save the cost of labor, raw materials, and energy. Reusable packaging is designed for repeated use; it is more durable and stronger than single-use packaging. The single-use solution segment is expected to grow at the fastest rate in the market during the forecast period of 2025 to 2034. Single-use pharmaceutical temperature controlled packaging solutions are validated to maintain controlled temperatures for up to 48 hours, ensuring the integrity of temperature sensitive goods throughout their transport. Every single use package is rigorously tested and qualified to prevent spoilage and ensure the safety of perishable goods throughout the transportation process. Application Insights The temperature-sensitive pharmaceuticals segment accounted for a considerable share of the pharmaceutical temperature controlled packaging solutions market in 2024. By monitoring temperature and making the necessary adjustments, temperature controllers help maintain a constant temperature in a laboratory or industrial space. This ensures the quality of healthcare products and the smooth operation of pharmaceutical equipment. Pharmaceutical packaging is important due to it protects the drugs from contamination, damage, and degradation, and helps to maintain their efficacy, quality, and safety. The vaccines segment is projected to experience the highest growth rate in the market between 2025 and 2034. The packaging of vaccines is important in maintaining their temperature during transportation. The packaging solutions must be designed to keep the vaccines within the required range, generally between 2°C and to 8°C. Temperature monitoring systems play an important role in preventing wastage. Using these systems saves the vaccines and reduces the financial and logistical burden associated with replacing wasted quantities, ensuring cost-effective and more efficient distribution. Browse More Research Reports: The U.S. temperature controlled packaging solutions market size surpassed USD 4.51 billion in 2024 and is predicted to reach around USD 10.99 billion by 2034, registering a CAGR of 9.31% from 2025 to 2034. The global high temperature ceramics market size was estimated at USD 7,900 million in 2024 and is projected to be worth around USD 15,830 million by 2034, growing at a CAGR of 7.2% from 2025 to 2034. The global time temperature indicator labels market size was estimated at USD 999 million in 2024 and is projected to be worth around USD 1,707 million by 2034, growing at a CAGR of 5.5% from 2025 to 2034. The global high-temperature honeycomb sandwich Materials market size is estimated to be worth USD 1,678 million in 2024 and is anticipated to reach a value of USD 2,708 million by 2034. Sales are projected to rise at a CAGR of 4.9% over the forecast period between 2024 and 2034 from 2025 to 2034. The global temperature controlled packaging solutions market size was estimated at USD 15.98 billion in 2024 and is projected to be worth around USD 38.81 billion by 2034, growing at a CAGR of 9.28% from 2025 to 2034. Ready to Dive Deeper? Visit Here to Buy Databook & In-depth Report Now@ Competitive Landscape in the Pharmaceutical Temperature Controlled Packaging Solutions Market Pelican Biothermal: They offer the widest range of temperature-controlled, thermally protected packaging and service solutions to the global life science industry. Cryopak: Cryopak designs and manufactures cold chain packaging solutions and refrigerants for temperature-sensitive pharmaceutical, biotech, and life sciences shipments. Sonoco Products Company: Sonoco Products Company is an American provider of diversified consumer packaging, industrial products, protective packaging, and supply chain services, and the world's largest producer of composite cans, tubes, and cores. Envirotainer: They offer the widest choice of cold chain solutions and a range of shipment monitoring services, all backed by their extensive global network. DS Smith Pharma: They develop packaging machines designed for forming and sealing cases for sensitive products. Cold Chain Technologies: Cold Chain Technologies (CTT) is a leading global provider of reusable, sustainable, thermal packaging and digital solutions for the shipment of temperature-sensitive material, principally serving the life science industry. World Courier: They deliver peace of mind through world-class supply chain programs, transport services, decentralized clinical trial support, and storage. Intelsius: Intelsius is a leading innovator in the biotechnology and life sciences sector, specializing in the development and provision of cutting-edge temperature controlled packaging solutions, compliant sample transport packaging, and integrated logistics services. CSafe: CSafe provides cold chain packaging and logistics services designed to maintain high-value, temperature-sensitive biopharmaceutical cargo. Softbox Systems: Softbox Systems is a manufacturer of temperature control packaging systems and thermal covers for the biotechnology, pharmaceutical, and life science industry. Skycell: They combine innovative hardware, smart software, and expert services to help pharma companies, airlines, and logistics providers reduce risk, cost, and emissions across their supply chains. Va-Q-tec AG: Va-Q-tec develops, produces, and markets vacuum insulation panels and phase change materials in Germany, the rest of the European Union, and internationally. Sofrigam: Sofrigam offers thermal insulated and cooling packaging solutions that are efficacious and economical for air, sea, and overland shipping and transport. What Are the Latest Developments in the Pharmaceutical Temperature Controlled Packaging Solutions Market? In July 2025, the Nordick Express Pack, a first-of-its-kind packaging system engineered specifically for the shipment of GLP-1 medications, marking a significant advancement in cold chain logistics for the pharmaceutical industry, was introduced by Nordic Cold Chain Solutions. GLP drugs highly used in diabetes and weight management therapies, require strict temperature control throughout the shipping process to preserve their efficacy and meet regulatory standards. Source: My Chesco In January 2025, TailorTemp, described as the 'latest radical innovation' within temperature controlled packaging for the pharmaceutical industry, was launched by DS Smith. TailorTemp is designed to support the sustainability targets of pharmaceutical and biotech businesses, meeting their need to store and transport delicate medicinal products across multiple territories within 'rigorously controlled' temperature environments. Source: Packaging Scotland Pharmaceutical Temperature Controlled Packaging Solutions Market Segments Covered in the Report By Product Reusable Solutions Single Use Solutions By Application Temperature-Sensitive Pharmaceuticals Vaccines Others By Geography North America U.S. Canada Europe U.K. Germany France Asia-Pacific China India Japan South Korea Malaysia Philippines Latin America Brazil Rest of Latin America Middle East & Africa (MEA) GCC North Africa South Africa Rest of the Middle East & Africa What's Next for the Market?As global demand for specialty drugs and biologics surges, the need for advanced, reliable temperature-controlled packaging solutions grows in parallel. Both markets are expected to benefit from heightened R&D, strategic collaborations, and emerging technologies that streamline cold chain operations. You can place an order or ask any questions, please feel free to contact us at sales@ Statifacts offers subscription services for data and analytics insights. This page provides options to explore and purchase a subscription tailored to your needs, granting access to valuable statistical resources and tools. Access here - Contact US Ballindamm 22, 20095 Hamburg, Germany Web: Europe: +44 7383 092 044 About US Statifacts is a leading provider of comprehensive market research and analytics services, offering over 1,000,000 market and custoer data sets across various industries. Their platform enables businesses to make informed strategic decisions by providing full access to statistics, downloadable in formats such as XLS, PDF, and PNG. Our Trusted Data Partners: Precedence Research | Towards Healthcare | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Dental | Towards EV Solutions | Nova One Advisor Pharmaceutical Temperature Controlled Packaging Solutions Market FAQs 1. What is driving demand for temperature-controlled packaging in the U.S.?The rapid growth of biologics, vaccines, gene therapies, and personalized medicines which require strict thermal protection alongside increasing clinical trials and regulatory safety mandates, is fueling demand. Likewise, COVID-era logistics models have entrenched cold-chain expectations. 2. What types of packaging solutions dominate and which are the fastest-growing?Reusable passive insulated shippers (e.g., metal or PCM-based containers) are currently dominant due to cost-efficiency and sustainability. The fastest growth is seen in smart active systems featuring IoT sensors and real-time data logging. 3. Which pharmaceutical products rely most heavily on cold-chain packaging?Vaccines and temperature-sensitive biologics including monoclonal antibodies and mRNA treatments are the primary users, as even brief thermal excursions can compromise potency and patient safety. 4. What major market trends are shaping product development and adoption?Trends include digital integration (blockchain, AI-enabled monitoring), reusable packaging systems to reduce waste, and ultra-low temperature (e.g., –70 °C) shippers for advanced therapies and gene-based products. 5. What challenges does this market face?Key barriers include high initial cost for active and ultra-cold systems, regulatory validation requirements, and limited last-mile infrastructure, especially for small-volume clinical or home delivery in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
